Gut Microbiome: Health, Disease, and Personalized Therapies
*Corresponding Author:Received Date: Aug 01, 2025 / Accepted Date: Aug 29, 2025 / Published Date: Aug 29, 2025
Citation: Tanaka PH (2025) Gut Microbiome: Health, Disease, and Personalized Therapies. Int J Inflam Cancer Integr Ther 12: 352.DOI: 10.4172/2381-8727.1000352
Copyright: © 2025 Prof. Hiro Tanaka This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
The gut microbiota is a critical determinant of host health, influencing immunity, metabolism, and the nervous system. Dysbiosis is associated with various diseases, including inflammatory and oncological conditions. Alterations in the gut microbiome impact cancer development and response to therapies, especially immunotherapy. Integrative medicine employs strategies like diet, probiotics, and fecal microbiota transplantation to restore microbial balance. The gut-brain axis and the production of short-chain fatty acids are key mechanisms of interaction. Understanding these complex relationships offers promising avenues for personalized therapeutic interventions.
